2018ACR适宜性标准_前列腺癌治疗后随访.pdf

APPROPRIATE USE CRITERIA ACR Appropriateness Criteria Post-treatment Follow-up Prostate Cancer a b Expert Panel on Urologic Imaging: Adam T. Froemming, MD , Sadhna Verma, MD , Steven C. Eberhardt, MDc d e f , Aytekin Oto, MD , Lauren F. Alexander, MD , Brian C. Allen, MD , Fergus V. Coakley, MDg h i j , Brian J. Davis, MD, PhD , Pat F. Fulgham, MD , Keyanoosh Hosseinzadeh, MD , Christopher Porter, MDk l m n , V. Anik Sahni, MD , David M. Schuster, MD , Timothy N. Showalter, MD, MPH , Aradhana M. Venkatesan, MD o p q , Carolyn L. Wang, MD , Erick M. Remer, MD Abstract Diagnosis and management of prostate cancer post treatment is a large and complex problem, and care of these patients requires multidisciplinary involvement of imaging, medical, and surgical specialties. Imaging capabilities for evaluation of men with recurrent prostate cancer are rapidly evolving, particularly with PET and MRI. At the same time, treatment options and capabilities are expanding and improving. These recommendations separate patients into three broad categories: (1) patients status post–radical prostatectomy, (2) clinical concern for residual